力星股份(300421.SZ):256萬股限制性股票將解鎖上市流通
格隆匯5月10日丨力星股份(300421.SZ)發佈關於2020年限制性股票激勵計劃第一個解鎖期解鎖股份上市流通的提示性公吿,此次可解鎖的限制性股票數量為256萬股,佔目前公司股本總額247,585,404股的1.0340%。此次符合解鎖條件的激勵對象共計56人。
該激勵計劃限制性股票授予登記完成之日為2021年1月26日,上市日為2021年2月1日。該激勵計劃第一個解鎖期為自授予登記完成之日起12個月後的首個交易日起至授予登記完成之日起24個月內的最後一個交易日當日止。截至目前,該激勵計劃的第一個解鎖期已屆滿12個月。
此次可解鎖股票上市流通時間為2022年5月16日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.